Introduction
Retrovirus vectors based on murine leukemia virus (MLV) have been used as powerful gene delivery systems in basic research and human gene therapy. [1] [2] [3] The introduced genes are stably integrated into the target cell genome and have the potential for long-term expression. Recently, retrovirus vectors pseudotyped with the G protein of vesicular stomatitis virus (VSV-G) have been constructed and shown to be advantageous in that they have a much broader host range, often yielding higher transduction efficiency, than conventional amphotropic retrovirus vectors and that virus stocks can be concentrated by ultracentrifugation to give a very high titer (approximately 1 × 10 9 IU/ml). [4] [5] [6] [7] Efficient production systems for these vectors have recently been developed by us 8 and by other groups, 9-11 making use of the CreloxP-mediated recombination system and inducible promoters, respectively.
Retrovirus vectors that can efficiently transduce antioncogenes or tumor suppressor genes with cytotoxic or cytostatic potential could be useful for gene therapy of human cancer. Such vectors might be produced by transient transfection of the vector DNA into packaging cell lines, but these systems are not suitable for the reproducible preparation of certified vectors on a large scale.
Establishment of stable packaging cell lines for such retrovirus vectors is difficult, because the growth-suppressing activity of these genes would cause problems in isolation of stable packaging cellular clones and their propagation in large-scale culture. Furthermore, the propagation step may potentially result in the accumulation of cellular populations carrying loss-of-function mutants of the tumor suppressor genes because of their growth advantage. Such difficulties would lower the quality and safety of the vectors, as discussed previously for an amphotropic retrovirus vector encoding p53. 12 To overcome these problems, we have designed a transcriptional unit for vector RNA production, pBabeLPL, in which the expression of the cytotoxic genes is completely silenced during cloning and propagation of the packaging cell lines. When this transcriptional unit was introduced into a prepackaging cell line PtG-S2, which we had previously developed, 8 the expression of both the exogenous gene in the vector and the VSV-G gene was induced in an all-or-nothing manner upon the introduction of Cre recombinase in an adenovirus vector. 13, 14 We show here that pBabeLPL in combination with PtG-S2 functioned as designed and was able to produce high titer virus stocks of VSV-G-pseudotyped retrovirus vector encoding p53. The virus stock transmitted the p53 gene into the entire population of several human tumor cell lines in a single transduction and induced cell cycle arrest of these cultures. 
Results
Design of retrovirus vectors for the expression of cytotoxic or cytostatic genes To overcome the difficulties in generating packaging cell lines which produce retrovirus vectors expressing cytotoxic or cytostatic genes, we first designed a transcriptional unit pBabeLPL-X (Figure 1a ) for vector RNA production. While it has a usual MLV-based proviral DNA structure, the exogenous gene X is preceded by an insertion carrying the puromycin resistance gene (puro) and a poly(A) addition signal flanked by a tandem pair of loxP sequences. The RNA transcript driven by the 5Ј-LTR would be expected to encode only the puro gene and to be terminated by the poly(A) addition signal present just before the X gene. Therefore, the X gene should not be transcribed from the 5Ј-LTR or from any other promoters, even when pBabeLPL-X is introduced into cells. In cells harboring pBabeLPL-X, the introduction of Cre recombinase will induce excision of the insertion (both the puro gene and the poly(A) addition signal) through loxP-specific recombination and the transcription of the X gene from the 5Ј-LTR will be initiated.
As the virus-producing cell system, we used the prepackaging cell line PtG-S2, which we had previously developed. 8 PtG-S2 constitutively expresses the gag and pol genes of MoMLV and also contains a Cre recombinase-inducible transcriptional unit, pCALNdLG, for the VSV-G gene (Figure 1a ). Neither RCR nor adenovirus vector was detected in pseudotyped virus stocks of 1 × 10 7 IU produced from PtG-S2. 8 After the introduction of an adenovirus vector encoding Cre recombinase, PtG-S2 harboring pBabeLPL-X would be expected to begin transcription of both full-length vector RNA driven by the 5Ј-LTR and VSV-G mRNA driven by a CAG promoter. 15 Thereafter, virus vector carrying the X gene will be packaged and produced from the packaging cell line just generated from the prepackaging cell line.
To develop this vector-producing system, we first used nlslacZ, the ␤-galactosidase gene with a nuclear localization signal, as a control gene (hereafter abbreviated as LacZ) and basic conditions for virus production, as well as the characteristics of the viral structure, were examined in PtG-S2 harboring pBabeLPL-lacZ (Figure 1b) . Using the conditions and procedures established for these cells, we further applied this system to a representative tumor suppressor gene p53, with cytostatic and cytotoxic potential, by generating PtG-S2 harboring pBabeLPL-p53 (Figure 1c) .
Isolation of prepackaging cell lines from which LacZ virus production can be induced pBabeLPL-lacZ (Figure 1b ) was transfected into PtG-S2 by lipofection and stable transformants were selected with puromycin. When mixed populations of puromycinresistant clones were collected and grown, no LacZexpressing cells were detectable in the entire culture, indicating that the LacZ gene is initially silent, as designed. When a subculture of the mixed populations was infected with the adenovirus vector AxCANCre 13, 14 at an MOI of 10, cells expressing LacZ became detectable within 3 days. From a parallel subculture, culture fluids were recovered every day and virus production was determined by titrating the LacZ-expressing retrovirus vectors with rat fibroblast 3Y1 cells as the indicator. The mixed populations of these transfectants of PtG-S2 produced 2 × 10 4 IU/ml of LacZ-expressing retrovirus vectors around 5 to 7 days after the introduction of Cre recombinase ( Figure 2a ). The induction kinetics of the vectors were slightly delayed compared with those of PtG-S2 harboring pMFGnlslacZ (PtG-S2 lacZ1) and the highest titer was about 1/50 of that of PtG-S2 lacZ1. The slight delay in the induction kinetics might be partially explained by the fact that two independent Cre-loxP recombination events are required for the virus production in PtG-S2 harboring pBabeLPL-lacZ.
In order to improve the production of retrovirus
Figure 2 Time-course of VSV-G-pseudotyped retrovirus production after transduction with AxCANCre at an MOI of 10. (a) Induction kinetics of virus carrying LacZ from cellular clones of PtG-S2 harboring pBabeLPLlacZ; A48 (closed circles), B19 (open triangles) or from the parental mixed population (closed squares). (b) Induction kinetics of virus carrying p53 from cellular clones of PtG-S2 harboring pBabeLPL-p53; C1 (open triangles), C58 (closed circles), C72 (closed squares) and D18 (open squares). None of these cultures produced retrovirus vectors in the absence of Cre recombinase. Results from A48 ((a); open circles) and C58 ((b); open circles) that were kept without the introduction of AxCANCre are
shown. Cells were kept at 37°C until 2 days after the transduction and were shifted to 32°C thereafter.
vectors, we isolated 182 clones of stable transformants of pBabeLPL-lacZ after selection with puromycin. None of the clones expressed LacZ or produced LacZ-expressing retrovirus vectors before the introduction of Cre recombinase, as observed above. A subculture of each clone was infected with AxCANCre at an MOI of 10 and the induction of LacZ expression in the culture was examined 6 days later. Twenty clones showing high level induction as monitored by X-gal staining were selected, and shown to produce LacZ with titers more than 2 × 10 4 IU/ml on day 6. Among them, two clones (A48 and B19) produced high titer retrovirus vectors (A48; 4 × 10 5 IU/ml) with similar kinetics of virus induction to mixed populations ( Figure 2a ). After high levels of vector production (6 or 7 days after adenovirus infection), the virus titer declined gradually possibly due to the cytotoxic effects of VSV-G protein. Experiments using different MOIs of AxCANCre indicated that an MOI of 10 reproducibly gave the highest titers, and this condition was employed thereafter. Since the structural analysis of PtG-S2 harboring pBabeLPL-lacZ and of 3Y1 transduced with the stocks of the LacZ virus indicated that DNA recombination and virus production proceeded precisely as designed (see below), we next applied this system for p53 virus production.
Isolation of prepackaging cell lines from which p53 virus production can be induced To produce p53-expressing retrovirus vectors, we constructed pBabeLPL-p53 (Figure 1c) , transfected it into PtG-S2, and isolated 168 clones of stable transformants by puromycin selection. Parallel cultures of these clones were infected with AxCANCre at an MOI of 10, and culture fluids were collected 6 and 8 days after the introduction of Cre recombinase. The titers of the virus stocks were determined by transduction on to 3Y1 and counting of p53-producing cellular clones after immunocytochemical staining. Twelve cellular clones that produced virus stocks with higher titers than 1 × 10 4 IU/ml were selected; none produced p53-expressing retrovirus vectors before the introduction of Cre recombinase. We further selected four clones (C1, C58, C72 and D18) on the basis of reproducibility in virus induction and high virus-producing activity (C58; 4 × 10 4 IU/ml), though the induction kinetics of the vectors were variable among them (Figure 2b ). These virus stocks could easily be concentrated by ultracentrifugation to 1 × 10 8 IU/ml. Proviral DNA analysis confirmed virus production as designed To test whether the loxP-specific recombination occurred in pBabeLPL as designed, proviral DNA in PtG-S2 chromosome was analyzed by Southern blotting using a LacZ probe before or 5 days after the introduction of AxCANCre (Figure 3a) . A single 5.9-kb band was detected in the KpnI digests before the introduction of Cre recombinase, but the density of the band was drastically reduced and a new 4.8-kb band appeared instead after the introduction. This change in the size of the LacZ fragment is consistent with the expected structural change accompanying Cre recombinase-mediated recombination between the two loxP sequences in pBabeLPLlacZ, as illustrated in Figure 1b . By comparing the density of chromosomal DNA with that of control chromosomal DNA from PtG-S2 lacZ1 8 harboring four copies of MFGnlslacZ per diploid, A48 was shown to contain a single copy of pBabeLPL-lacZ in the diploid cell before the introduction of Cre recombinase. After the introduction, the copy number increased to two to three copies per diploid, as shown in Figure 3a . This result would indicate that the LacZ virus has propagated in the packaging cell lines by 5 days after the introduction of Cre recombinase, because VSV-G-pseudotyped virus was previously shown to be fully infectious to VSV-G-expressing cells such as PtG-S2 into which Cre recombinase had been introduced. 8 We next analyzed chromosomal DNA of C1, C58, C72 and D18 by Southern blotting to examine the structural changes in pBabeLPL-p53. Chromosomal DNA was isolated before or 4 days after the introduction of AxCANCre. The samples were doubly digested with KpnI and XbaI and analyzed with a p53 probe, or digested with KpnI and analyzed with a gag probe (Figure 1c) . The size changes observed by the p53 probe (2.5 kb to 3.4 kb) or by the gag probe (4.6 kb to 3.5 kb) are consistent with the idea that Cre recombinase had excised the insertion between the two loxP sequences by site-specific recombination. A comparison of the densities of the bands indicates that the copy numbers were drastically increased by the introduction of Cre recombinase in all the clones (Figure 3b ). In C1, we additionally detected an unexpected 3.3-kb band with either the p53 or gag probe before the introduction of Cre recombinase (Figure 3b , top and bottom panels), and found that it disappeared after the introduction. This result suggests that the C1 chromosome contains one copy of pBabeLPL-p53 which has an altered structure from that in the original plasmid and we eliminated this clone from further analysis.
By chromosomal analysis of clone A48, or C58, we also showed that in pCALNdLG the loxP-specific recombination was almost completed by 4 days after the introduction of Cre recombinase (data not shown), as has also been shown for the parental strain PtG-S2. These chromosomal changes are consistent with the kinetics of LacZ virus or p53 virus production; the virus production was highest from 4 days after the introduction of Cre recombinase.
To examine the integrated structures of transduced retrovirus vectors, LacZ virus or p53 virus was transduced into 3Y1 at an MOI of 10 or 3, respectively. Chromosomal DNA was isolated before or 3 days after the transduction, digested with KpnI, and analyzed by Southern blotting using LacZ or p53 probe. A single 4.8-kb band was detected in the LacZ virus-transduced cells and a 3.5-kb band was detected in the p53 virus-transduced cells (Figure 3c ). These bands were not detected before the virus transduction. Therefore only retrovirus vectors with the designed structure were integrated into the target cells.
Transduction of the p53 virus into several cell lines and its biological effects
To test the biological activity of the p53-carrying virus prepared here, a pair of growing cultures of either 3Y1 (rat fibroblast) or U2-OS (originated from human osteosarcoma) was prepared and transduced with the p53 virus at an MOI of 10. In both cell lines, the entire populations of the transduced culture were shown to express p53 protein at high levels within 65 h as judged by immunocytochemical staining using anti-p53 (human) antiserum (Figure 4 right panels) and no cells were unstained. The cell numbers of transduced cultures were much lower than those of cultures left untransduced, indicating that cell growth was strongly inhibited in the transduced cultures. It was also clear that all the cells transduced with the p53 virus exhibited a much flatter morphology than the untransduced cells ( Figure 4 , left panels). Endogenous p53 expression in 3Y1 was not detectable because the antiserum is non-crossreactive to rat p53, while low level expression of endogenous p53 was detected in untransduced U2-OS.
When the amounts of human p53 protein in these cells were analyzed by Western blotting using the same antip53 (human) antiserum, strong induction of p53 protein was confirmed. The analysis of parallel cultures transduced with p53 virus at an MOI of 1 indicated that the p53 expression levels increased in a dose-dependent manner and further that the p53 expression level induced by UV irradiation was roughly equivalent to that induced by retrovirus transduction at an MOI of 1 ( Figure 5) .
To assess the effects of p53 virus on cell growth more precisely, these two cell lines as well as PtG-S2, the parental prepackaging cell line originated from the human fibrosarcoma cell line, HT1080, were transduced with this virus at an MOI of 10 and analyzed by flow cytometry after propidium iodide staining. All three cell lines transduced with p53 virus showed a marked decrease in the proportion of cells in S phase and a significant increase in the proportion of cells in G1 phase ( Figure 6 , Table 1 ), when compared with control cultures transduced with LacZ virus at an MOI of 10, as well as untransduced cultures (data not shown). These results indicate the expression of p53 results in the G1 arrest of these cell lines at the G1-S transition. 
Discussion
We have presented here a unique system for the production of retrovirus vectors carrying cytotoxic or cytostatic genes. pBabeLPL can be employed as an inducible transcriptional unit for the vector RNA encoding an exogenous gene in an all-or-nothing manner using the Cre-loxP recombination system. We can select prepackaging cell lines without any production of vector RNA bearing the exogenous gene during the selection and subsequent passaging procedures. Even before the introduction of Cre recombinase, a part of the vector RNA with the puromycin resistance gene is transcribed from the 5Ј-LTR of pBabeLPL and terminated by the SV 40 poly(A) addition signal. In the culture medium of PtG-S2 derivatives such as A48, B19, C1, C58, C72 and D18, however, we have never detected any vector particles transmitting puro resistancy to 3Y1 (our unpublished result) either before or after the introduction of Cre recombinase. While the Cre-loxP recombination system was used here for the induction of the cytotoxic exogenous genes, it has also been used in the context of retrovirus-mediated gene transfer for the generation of selfdeleting vectors, 16, 17 for the removal of proviral marker genes, [18] [19] [20] and for the exchange of the exogenous genes in a packaging cell line. 21 In our system, induction of both the X gene in pBabeLPL-X and the VSV-G gene in pCALNdLG is mediated through Cre-loxP recombination. While site-specific recombination by Cre recombinase has been reported to be quite rare if the two loxP sequences are distantly located in the same chromosome or located in different chromosome, 22 it is theoretically possible for the site-specific recombination to occur between the loxP sequences in pBabeLPL-X and pCALNdLG. However, we did not detect any of the bands that would be expected from such recombinations (Figure 3b) , even in an autoradiogram of the same gel exposed for 10 times longer (our unpublished results). Such recombinations would generate a structure, 5Ј-LTR-loxP-VSV-G-poly(A) addition signal, which could be further converted to produce packageable and transmissible transcripts after a single non-homolo-gous recombination. We have carefully checked whether such particles that can transmit the VSV-G gene were present in our virus stocks, but we were not able to detect such particles at all in 5 × 10 6 IU of the vectors. Therefore, such recombination was negligible, at least at 5-6 days after the introduction of Cre recombinase. The proviral DNA analysis further confirmed that only DNA forms with the designed structure were transmittable to the transductants.
Using this retrovirus production system, we have succeeded in generating stable packaging cell lines which can produce high-titer p53-expressing VSV-G-pseudotyped retrovirus vector. When this vector was transduced into 3Y1, U2-OS and PtG-S2 at an MOI of 10, exogenous p53 expression was induced in all the cells at quite high levels and essentially none of the cells in the entire culture escaped transduction. Therefore this system should permit us to examine the effect of introducing cytotoxic genes into an entire cellular population without any prior selection. Since the transduction of the p53-carrying virus into the parental prepackaging cell line, PtG-S2, induced cell cycle arrest ( Figure 6 , Table 1 ), a stable cell line which constitutively expresses p53 should not be established.
Due to its widespread alterations in malignant cells and its central position in both proliferation arrest and apoptosis induction, p53 has been the most investigated gene for cancer gene therapy. [23] [24] [25] [26] [27] [28] In most experiments, gene transfer efficiencies have been below 100%, 29 so the antitumoral effect of p53 relies strongly on 'by-stander killing' effects. 24, 27, 30, 31 In contrast by using the VSV-Gpseudotyped retrovirus vectors developed here, it should be possible to transduce exogenous genes into the entire population of monolayer cultures originated from human cell lines (Figure 4a ), even if the exogenous genes are cytostatic or cytotoxic, like p53.
Materials and methods
Plasmid construction The 1.0-kb SaII-ClaI fragment (carrying an internal promoter and the puro gene) of pBabe puro 32 (a kind gift from Dr H Land, Imperial Cancer Research Fund) was deleted and replaced with the linker oligonucleotides (5Ј TCGACGCAGATCTCACGTGATTTAAATAT 3Ј and 5Ј CGATATTTAAATCACGTGAGATCTGCG 3Ј) to generate pBabe. The 1.1-kb HindIII-BamHI fragment carrying the puro gene and SV 40 poly(A) addition signal was excised from pPUR (Gibco-BRL, Rockville, MD, USA) and ligated into the 2.5-kb HindIII-BamHI fragment of pBS246 (Gibco-BRL) that is flanked with loxP sequences at both ends. The 1.2-kb loxP-puro-SV 40 poly(A)-loxP fragment was excised from the generated plasmid by digesting with both EcoRI and ScaI, blunt-ended with Klenow fragment, and inserted into the unique SnaBI site of pBabe to generate pBabeLPL. The BamHI fragment encoding the entire nlslacZ or p53 was excised from pMFGnlslacZ 33 or pCMV-NEO-BAM-p53 23 and inserted into the unique BgIII site of pBabeLPL to generate pBabeLPL-lacZ and pBabeLPL-p53, respectively.
Cell lines
The prepackaging cell line PtG-S2 8 (a derivative of human fibrosarcoma cell line HT1080, which carries the gag and pol genes from Moloney MLV (MoMLV) and a VSV-G gene (Indiana serotype) that is silent before the introduction of Cre recombinase), 3Y1 (rat fibroblast) and U2-OS (human osteosarcoma) were maintained in Dulbecco's modified Eagle's medium (DMEM) (high glucose) supplemented with 10% fetal calf serum and kept at 37°C. PtG-S2 and its derivatives were grown in the presence of 4 g of blasticidin S (Funakoshi, Tokyo, Japan) and 1 mg of G418 (Gibco-BRL) per milliliter. Drug selection for the transfected PtG-S2 was performed with 2 g of puromycin (Sigma, St Louis, MO, USA) per ml.
DNA transfection and cloning of the transfectants PtG-S2 was seeded at 2 × 10 6 cells/100-mm diameter dish, kept for 1 day and transfected with either pBabeLPL-lacZ or pBabeLPL-p53 (4 g) by the use of Lipofectamine Plus Reagent (Gibco-BRL). Two days after the transfection, the cultures were split at several ratios, and puromycin (final concentration, 2 g/ml) was added to the medium 3 or 4 days after the transfection to select stable transfectants. Puromycin-resistant colonies were picked up with cloning cylinders and propagated.
Adenovirus vector infection for pseudotyped retrovirus production PtG-S2 and its derivatives were kept at 37°C, seeded at 7.5 × 10 5 cells per 100-mm diameter dish, kept for 1 day and infected with AxCANCre at a multiplicity of infection (MOI) of 10. G418 and puromycin were removed from the culture medium just before the AxCANCre infection. From two days after the adenovirus infection, the cultures were kept at 32°C to obtain a slightly more stable production of VSV-G-pseudotypes. The medium was changed every day and at each medium change, retrovirus vector stocks were recovered.
Southern blot analysis
Total chromosomal DNA was prepared using standard techniques from PtG-S2, 3Y1 and their derivatives. The digested DNA was separated on 1.0% agarose gel and transferred to a nylon membrane (Hybond N+; Amersham, Buckinghamshire, UK) by the capillary transfer method. The 3.1-kb LacZ probe was isolated from pMFGnlslacZ by BamHI digestion. The 1.8-kb p53 probe was isolated from pCMV-NEO-BAM-p53 by BamHI digestion. The 0.7-kb gag probe was isolated from pBabe by SpeI and BamHI digestion. The probes were labeled with 32 P-␣-CTP by using the RTS RadPrime DNA Labeling System (Gibco-BRL), hybridized and detected by autoradiography.
Protein analysis
For Western blot analysis, cellular lysates were prepared under denaturing conditions and separated by sodium dodecyl sulfate-10% polyacrylamide gel electrophoresis. The gels were transferred on to polyvinylidene difluoride membrane (Immobilon; Millipore, Bedford, MA, USA) with a semi-dry electroblotter. Filters were immunoblotted first with monoclonal anti-p53 (human) IgG (Pab 1801; Santa Cruz, Santa Cruz, CA, USA) that is non-crossreactive to either mouse or rat p53 and then with antimouse IgG horseradish peroxidase-linked whole antibody (Amersham). Protein bands were detected with an ECL kit (Amersham). For immunocytochemical staining, cells were fixed with PBS containing 2% paraformaldehyde and 0.1% Triton X-100 at 4°C for 15 min and reacted with monoclonal anti-p53 (human) IgG (DO-1; Santa Cruz), which is non-crossreactive to either mouse or rat p53. p53-producing cells were visualized using biotinylated anti-mouse IgG and a Vectastain ABC kit (Vector, Burlingame, CA, USA).
Retrovirus transduction and titration
For the titration of VSV-G-pseudotyped retrovirus vectors, the indicator cell line 3Y1 was plated at 7.5 × 10 2 -1.5 × 10 3 cells per well in 96-well plates and kept for 1 day before transduction. For transduction, cells were incubated with serial dilutions of virus supernatants in the presence of 8 g/ml polybrene (Sigma) and kept for a further 3 days. For X-gal staining transduced 3Y1 was fixed with 1.25% glutaraldehyde and stained with 5 mm K 4 [Fe(CN) 6 ], 5 mm K 3 [Fe(CN) 6 ], 2 mm MgCl 2 and 1 mg/ml X-gal (5-bromo-4-chloro-3-indolyl-␤-d-galactopyranoside) (Wako, Osaka, Japan) for more than 4 h. The numbers of cellular clones with blue-stained nuclei were counted. Expression of p53 (human) protein was evaluated by immunocytochemical staining using monoclonal anti-p53 (human) IgG (DO-1; Santa Cruz) and visualized as described above. The numbers of cellular clones with brown-stained nuclei were counted.
Cell cycle analysis Cells were trypsinized, fixed with 90% ethanol and resuspended in PBS solution containing 2 mg/ml of Rnase A (Sigma) and 50 g/ml of propidium iodide (Sigma). The stained cells were analyzed in a fluorescence-activated cell sorter (FACScan; Becton Dickinson, Franklin Lakes, NJ, USA). The percentages of cells in various cell cycle phases were determined by using the CellQuest and ModFit program.
